Back to search results

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Uveal Melanoma · Ocular Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Principal Investigator (Nikhil I Khushalani, MD)
    Andrew Brohl, MD (Sub-investigator)
    Zeynep Eroglu, MD (Sub-investigator)
    Joseph Markowitz, MD, PhD (Sub-investigator)
    Jane Messina, MD (Sub-investigator)
    Keiran Smalley, PhD (Sub-investigator)
    Ahmad Tarhini, MD, PhD (Sub-investigator)
Study leads

  • Nikhil I Khushalani, MD

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)